Investigational Product (IP) Management for Metabolic Clinical Studies

About

ProSciento has a dedicated Pharmaceutical Services (PS) Group that oversees investigational product (IP) management and related specialized services for multicenter, multinational metabolic clinical trials for biopharmaceutical clients worldwide. The PS Group consists of pharmacists and researchers with longstanding expertise in clinical research and stable isotope tracer studies.

Investigational Product (IP) Management for Metabolic Clinical Studies thumbnail

Recommended Materials

Investigational Product (IP) Management for Metabolic Clinical Studies thumbnail

Posters

Effect of Dawn Phenomenon on Glucose Infusion Rate During Glucose Clamp Studies In Subjects with Type 1 Diabetes

Investigational Product (IP) Management for Metabolic Clinical Studies thumbnail

Posters

DA-1241 a novel GPR119 agonist: Safety, tolerability, pharmacokinetics, and pharmacodynamics: Part 2 of multiple ascending dose study in type 2 diabetes patients

Investigational Product (IP) Management for Metabolic Clinical Studies thumbnail

Posters

The novel glucagon receptor agonist SAR438544, first in human safety, pharmacokinetic and pharmacodynamic data from a study in healthy volunteers

Related Solutions

Stable Isotope Tracer Methodologies thumbnail

Specialized Methods

Overview thumbnail

Our Services